Releases
Saluda Medical Performs First U.S. Procedures With CAP24 Paddle Lead
Surgeons in Arkansas and Pennsylvania have completed the first U.S. implantations of the CAP24 paddle lead, marking the debut of closed-loop neuromodulation for patients requiring this specific surgical hardware. The procedure, cleared by the FDA, allows Saluda Medical to expand its Evoke therapy into the paddle-based spinal cord stimulation market.


























